Calyxt Appoints Bobby Williams as Gene Editing Director to Expand Innovation and Product Pipeline
January 23 2020 - 9:00AM
Business Wire
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company,
has appointed Bobby Williams, Ph.D. to the newly created role of
Director of Gene Editing to further expand Calyxt’s innovation,
product pipeline, and trait discovery efforts and inform product
advancement decisions.
Dr. Williams has been on the forefront of advancements in plant
sciences, and is an expert in the gene editing field. His
accomplishments include developing new gene silencing technology
and leading efforts to discover small RNAs to precisely engineer
beneficial crop traits. In addition, Dr. Williams led gene
discovery initiatives to improve crop traits to support
sustainability, specifically drought resistance, improved nitrogen
efficiency and yield enhancement.
“The addition of Bobby to the R&D team empowers us to
further leverage our technology and develop next generation
products to solve unmet consumer, marketplace and environmental
demands,” said Travis Frey, chief technology officer with Calyxt.
“A talented and disciplined inventor, Bobby can immediately
contribute to our pipeline with his gene editing and discovery
prowess and innovative thinking,” concluded Frey.
“Calyxt is an innovation platform company and we believe the
successful commercial launch of our HO soybean products proves
there is demand for gene-edited products,” said Jim Blome, chief
executive officer of Calyxt. “The potential benefits of gene-edited
products to foodservice and food manufacturing companies
(performance), consumers (health) and the planet (sustainability)
are significant. We aim, through science, to benefit both people
and planet and look forward to accelerating this initiative through
Bobby’s addition,” concluded Blome.
With more than 15 years of expertise in the agriculture and seed
industry, Dr. Williams most recently served as Senior Research
Manager at Corteva Agriscience, where he led multiple trait
discovery efforts and cross functional teams through field
advancements. Prior to Corteva, Dr. Williams was a Helen Hay
Whitney post-doctoral fellow at UC Berkeley studying Drosophila
development under Gerald Rubin, Ph.D. He earned his Ph.D. in
Biology at the California Institute of Technology in Pasadena, CA
where he focused on plant developmental genetics with Elliot
Meyerowitz, Ph.D.
About Calyxt
Calyxt (NASDAQ: CLXT), based in Roseville, Minnesota is a
plant-based technology company that utilizes our patented breeding
technology to make the food you love a healthier choice. The care
we take extends beyond nutritional value. We partner with farmers
and food companies to deliver traceable plant-based products
developed to be healthier and more sustainable than their
conventional counterparts. We use cutting edge plant breeding
techniques to develop products that help improve diets by reducing
bad fats, allergens and toxins. Today oil from our high oleic
soybean plants has lower saturated fats than commodity soybean oil.
We are also developing high fiber wheat designed to provide an
excellent source of daily fiber when incorporated into wheat-based
foods. We continuously pursue innovation to deliver good food that
is good for you. For further information, please visit our website
at www.calyxt.com.
Calyxt Forward-Looking Statements
This communication contains “forward-looking statements” within
the meaning of the safe harbor provisions of the U.S. Private
Securities Litigation Reform Act of 1995. In some cases, you can
identify these statements by forward-looking words such as “may,”
“might,” “will,” “should,” “expects,” “plans,” “anticipates,”
“believes,” “estimates,” “predicts,” “potential” or “continue,” the
negative of these terms and other comparable terminology. These
forward-looking statements, which are subject to risks,
uncertainties and assumptions about us, may include projections of
our future financial performance, our anticipated growth strategies
and anticipated trends in our business. These statements are only
predictions based on our current expectations and projections about
future events. There are important factors that could cause our
actual results, level of activity, performance or achievements to
differ materially from the results, level of activity, performance
or achievements expressed or implied by the forward-looking
statements, including those factors discussed under the caption
entitled “Risk Factors” in our Annual Report on Form 10-K, along
with our other filings with the U.S. Securities and Exchange
Commission. We do not assume any obligation to publicly provide
revisions or updates to any forward-looking statements, whether as
a result of new information, future developments or otherwise,
should circumstances change, except as otherwise required by
applicable laws.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200123005457/en/
Media contact Trina Lundblad, Director of Corporate
Communications Phone: +1 (612) 790-0514 email: media@calyxt.com
Investor Relations contact Chris Tyson Managing Director
MZ Group – MZ North America (949) 491-8235 CLXT@mzgroup.us
www.mzgroup.us
Calyxt (NASDAQ:CLXT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Calyxt (NASDAQ:CLXT)
Historical Stock Chart
From Sep 2023 to Sep 2024